SIRT2 and mucinous adenocarcinoma: SIRT2 inhibits METTL16 Kla, and combining the SIRT2 inhibitor AGK2 with the ferroptosis inducer Eles significantly enhances the treatment of malignant gastric cancer, especially for mucinous adenocarcinomas with high copper content 117.